The necessity of CCL2 for mobilization of endothelial progenitor cells was demonstrated in a genetic murine breast cancer model, exhibiting reduced numbers of these cells in the blood in Her2/neu CCL2-deficient mice [209]. This evidence concerns the gene CCL2 and breast carcinoma.